Article
p53-armed oncolytic adenovirus induces autophagy and apoptosis in KRAS and BRAF-mutant colorectal cancer cells.
PloS one - 1 Jan 2023
Tamura Shuta, Tazawa Hiroshi, Hori Naoto, Li Yuncheng, Yamada Motohiko, Kikuchi Satoru, Kuroda Shinji, Urata Yasuo, Kagawa Shunsuke, Fujiwara Toshiyoshi
Abstract excerpt
Colorectal cancer (CRC) cells harboring KRAS or BRAF mutations show a more-malignant phenotype than cells with wild-type KRAS and BRAF. KRAS/BRAF-wild-type CRCs are sensitive to epidermal growth factor receptor (EGFR)-targeting agents, whereas KRAS/BRAF-mutant CRCs are resistant due to constitutive activation of the EGFR-downstream KRAS/BRAF signaling pathway. Novel therapeutic strategies to treat KRAS/BRAF...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
